Overexpression of active CDADC1 did not change sensitivity to cytarabine (Fig. 3A), a cytosine arabinoside used against leukemia and lymphoma and has a 2′OH (36), aligning with CDADC1’s biochemical preference for 2′-deoxynucleotides. This evidence concerns the gene CDADC1 and lymphoma.